Helix BioPharma : Announces Closing of Private Placement of CAD $3 Million and Board Changes -November 02, 2023 at 05:00 am EDT
August 21, 2023 Press Release 2704, 401 Bay Street Toronto, M5H 2Y4 Ontario Tel: 905-841-2300 ...
Stay updated with breaking news from Christopher Maciejewski. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
August 21, 2023 Press Release 2704, 401 Bay Street Toronto, M5H 2Y4 Ontario Tel: 905-841-2300 ...
Helix BioPharma Corp announced the appointment of Artur Gabor as the company's new permanent CEO, effective immediately. The clinical-stage...
RICHMOND HILL, ON / ACCESSWIRE / April 18, 2022 / Helix BioPharma Corp. (TSX:HBP) ("Helix" or the "Company"), a clinical-stage biopharmaceutical company developing unique therapies in the field of immuno-oncology
Helix BioPharma Corp announced the appointment of Artur Gabor as the company's new permanent CEO, effective immediately. The clinical-stage...